Cargando…
Serum VEGF levels as a predictor of recurrence in patients with advanced‑stage esophageal squamous cell carcinoma following curative esophagectomy followed by chemotherapy or concurrent radiotherapy
The present study evaluated serum levels of vascular endothelial growth factor (VEGF) as a predictor of recurrence in patients with advanced-stage esophageal squamous cell carcinoma (ESCC) following curative esophagectomy followed by chemotherapy or concurrent radiotherapy. Patients with locally adv...
Autores principales: | Xu, Heng, Cao, Haixia, Zhang, Junying, Jing, Changwen, Wang, Zhuo, Wu, Jianzhong, Du, Mengjie, Xu, Xuyun, Ma, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557093/ https://www.ncbi.nlm.nih.gov/pubmed/37809347 http://dx.doi.org/10.3892/mco.2023.2682 |
Ejemplares similares
-
Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015) -
Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal
por: Zhao, Zhiyong, et al.
Publicado: (2021) -
Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
por: Kim, Yong-Hyub, et al.
Publicado: (2015) -
Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer
por: Zingg, Urs, et al.
Publicado: (2009) -
The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2018)